[HTML][HTML] The theranostic promise for Neuroendocrine Tumors in the late 2010s-Where do we stand, where do we go?

RA Werner, A Weich, M Kircher, LB Solnes… - Theranostics, 2018 - ncbi.nlm.nih.gov
… evaluation of novel theranostic radiotracers for imaging … theranostic concept is currently
applied and also reflects on recent developments that hold promise for the future of theranostics

Neuroendocrine Tumor Theranostics: An Update and Emerging Applications in Clinical Practice

S Sheikhbahaei, MS Sadaghiani… - American Journal of …, 2021 - Am Roentgen Ray Soc
Theranostics have shown great promise for delivering precision medicine, particularly in
neuroendocrine tumors … –targeting radiopharmaceuticals with theranostic potential in NETs, …

Consensus on molecular imaging and theranostics in neuroendocrine neoplasms

V Ambrosini, J Kunikowska, E Baudin, L Bodei… - … journal of cancer, 2021 - Elsevier
… biomarkers (such as eg PPQ) hold promise as predictive biomarkers for PRRT and
should be … of response and toxicity when treating patients with neuroendocrine tumours [100,101]. …

Advances in molecular imaging and radionuclide therapy of neuroendocrine tumors

A Yordanova, HJ Biersack… - Journal of Clinical …, 2020 - mdpi.com
neuroendocrine tumors (NETs). Furthermore, imaging and treatment with novel theranostics
agents … New advances in nuclear medicine promise to enhance the detectability of NETs in …

[HTML][HTML] Molecular imaging radiotherapy: theranostics for personalized patient management of neuroendocrine tumors (NETs)

K Öberg - Theranostics, 2012 - ncbi.nlm.nih.gov
… A theranostic system integrates some form of diagnostic testing to determine the presence
… excitement of theranostics is its revolutionary approach that promises improved therapy …

Theranostics in oncology—thriving, now more than ever

RA Werner, T Higuchi, MG Pomper, SP Rowe - Diagnostics, 2021 - mdpi.com
… the use of the theranostic concept for neuroendocrine neoplasm (NEN), prostate cancer (PC)…
PSMA scan interpretation have been introduced, including PROMISE, E-PSMA or the PSMA…

Theranostics in Neuroendocrine Tumors

S Vallabhajosula - Molecular Imaging and Targeted Therapy …, 2023 - Springer
… receptor, SSTR) on the tumor cell surface. The radio-theranostic concept of using a molecular
… radionuclide therapy has shown great promise of personalized medicine of patients with …

Molecular imaging and therapy for neuroendocrine tumors

H Desai, S Borges-Neto, TZ Wong - Current treatment options in oncology, 2019 - Springer
… because neuroendocrine tumors … -theranostic concept of using a molecular marker for both
imaging and treatment has shown great promise in the treatment of neuroendocrine tumors

Imaging of neuroendocrine tumors: indications, interpretations, limits, and pitfalls

R Yu, A Wachsman - Endocrinology and Metabolism Clinics, 2017 - endo.theclinics.com
… 2MRI imaging features of liver metastatic lesions from a small bowel neuroendocrine
tumor. Images of about the same axial section are shown. (A) T2-weighted image. …

Theranostics: leveraging molecular imaging and therapy to impact patient management and secure the future of nuclear medicine

LB Solnes, RA Werner, KM Jones… - Journal of Nuclear …, 2020 - Soc Nuclear Med
… with metastatic gastroenteropancreatic neuroendocrine tumors. Predominantly retrospective
… deliver on the theranostic promise for the sake of our (often palliative) patients with cancer. …